Related references
Note: Only part of the references are listed.White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β
Whitney M. Freeze et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Imaging biomarkers of dementia: recommended visual rating scales with teaching cases
Lars-Olof Wahlund et al.
INSIGHTS INTO IMAGING (2017)
The role of cerebrovascular disease when there is concomitant Alzheimer disease
Prashanthi Vemuri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients
Byoung Seok Ye et al.
ALZHEIMERS & DEMENTIA (2015)
Combined Alzheimer's disease and cerebrovascular staging explains advanced dementia cognition
Maria Ascension Zea-Sevilla et al.
ALZHEIMERS & DEMENTIA (2015)
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
Prashanthi Vemuri et al.
BRAIN (2015)
White matter hyperintensities, cognitive impairment and dementia: an update
Niels D. Prins et al.
NATURE REVIEWS NEUROLOGY (2015)
What are White Matter Hyperintensities Made of? Relevance to Vascular Cognitive Impairment
Joanna M. Wardlaw et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
The overlap between vascular disease and Alzheimer's disease - lessons from pathology
Johannes Attems et al.
BMC MEDICINE (2014)
The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results
Pauline Aalten et al.
BMC NEUROLOGY (2014)
Variability of CSF Alzheimer's Disease Biomarkers: Implications for Clinical Practice
Stephanie J. B. Vos et al.
PLOS ONE (2014)
Cognitive aging in persons with minimal amyloid-p and white matter hyperintensities
Robert D. Nebes et al.
NEUROPSYCHOLOGIA (2013)
Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study
Ron L. H. Handels et al.
BMC NEUROLOGY (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Late and early onset dementia: What is the role of vascular factors? A retrospective study
Anna Carotenuto et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Vascular burden and Alzheimer disease pathologic progression
Raymond Y. Lo et al.
NEUROLOGY (2012)
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
Alida A. Gouw et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2010)
Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
Cees Mulder et al.
CLINICAL CHEMISTRY (2010)
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis
Stephanie Debette et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
The Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts
Julie A. Schneider et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease
P. J. Visser et al.
NEUROEPIDEMIOLOGY (2008)
The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia
Antonio J. Bastos-Leite et al.
STROKE (2007)
Current state and future directions of neurochemical biomarkers for Alzheimer's disease
Dankille de Jong et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
Ian G. McKeith
JOURNAL OF ALZHEIMERS DISEASE (2006)
Understanding the pathology of vascular cognitive impairment
KA Jellinger
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
ESC Korf et al.
NEUROLOGY (2004)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Potential biological markers for cerebrovascular disease
A Kurz et al.
INTERNATIONAL PSYCHOGERIATRICS (2003)
Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly
D Zekry et al.
ACTA NEUROPATHOLOGICA (2002)
CT and MRI rating of white matter lesions
F Fazekas et al.
CEREBROVASCULAR DISEASES (2002)
A new rating scale for age-related white matter changes applicable to MRI and CT
LO Wahlund et al.
STROKE (2001)
The abuse of power: The pervasive fallacy of power calculations for data analysis
JM Hoenig et al.
AMERICAN STATISTICIAN (2001)
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
C Hesse et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
